Month: November 2020

Researchers reported at the virtual scientific sessions of the American Heart Association that omega-3 fatty acids, formulated with carboxylic acid for greater bioavailability, made no difference in cardiovascular event rates in the STRENGTH trial, which was stopped early for futility. In this exclusive MedPage Today video, the Cleveland Clinic’s Steven Nissen, MD, chair of STRENGTH’s
0 Comments
It’s never easy deciding when to quit vs. when to persist. With any ambition in life, there will be challenges and obstacles in your way. Most of the the time the answer is to stick with it, endure, practice discipline, and grind it out. But in some instances, the best option, the brave option, is
0 Comments
As medical science has progressed, many tasks that doctors performed nearly a century ago are now considered specializations. Radiology is one such medical specialty that has continued to gain recognition and understanding ever since X-rays were discovered in 1895. While many people are involved in this branch of medicine, a few have become exceptional at it. Salah Qanadli
0 Comments
A dance between shadow and light that we can all relate to – we explore the meaning behind komorebi, and the lessons it can teach us about mental health Every time I look up from my desk, I see my favourite art print – The Shyness of Trees by Marcel George. Imagining you’re looking straight
0 Comments
Coronavirus cases are spiking across the country, and local and state governments are trying to curb the spread.  Here’s a synopsis of pandemic-created changes to review as we head into winter and the holiday season. In most cities, expect indoor dining to no longer be an option — it’s already happened in Philadelphia and St.
0 Comments
KENILWORTH, N.J.–(BUSINESS WIRE) November 16, 2020 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a collaboration with the Bill & Melinda Gates Foundation (the foundation) where the foundation is committing to provide funding to support a pivotal Phase 3 study investigating a once-monthly oral pre-exposure prophylaxis (PrEP)1
0 Comments
FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Zokinvy (lonafarnib) for the
0 Comments
After many years of good management of their high blood pressure, Americans are letting that control slip: the number of Americans with uncontrolled blood pressure rates has been rising. And while this trend has been creeping up since 2015, Covid-19, as with most things today, seems to have left its mark.   These increasing numbers aren’t
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The FDA issued an emergency use authorization to Regeneron Pharmaceuticals for its monoclonal antibodies — casirivimab and imbdevimab — to be administered together to treat mild-to-moderate COVID-19 in adults and kids over age 12. The treatment should be given to patients
0 Comments
‘Manifesting’ has become a real buzz word – and it’s one our columnist Grace Victory uses daily. Here, she shares everything you need to know about the power of ‘manifestation’ When I was 23, I began searching for ways to connect to myself moredeeply, as well as how to create a life that I really
0 Comments
Many of us are frittering away time on Facebook or Twitter as we hunker down at home during the pandemic. But there’s a potential upside to all this social media engagement: It lets public health officials know how people feel about Covid-19 restrictions and can be used to encourage compliance. Australian researchers found that social
0 Comments
A novel algorithm-based disease management program, led by pharmacists and nonlicensed navigators, optimized cholesterol and blood pressure levels in high-risk patients, according to an interim report from the first 5000 patients. Mean low-density lipoprotein cholesterol (LDL-C) levels fell from 125 mg/dL to 73 mg/dL among those who finished active treatment titration and from 133 mg/dL
0 Comments
Operation Warp Speed chief advisor Dr. Moncef Slaoui has had “no contact” with the incoming Biden administration regarding the transition process and vaccine distribution plans. Since President-elect Joe Biden won the election, President Donald Trump has refused to concede and his campaign has challenged the results of the election in court. Despite his lack of communication with the
0 Comments
Reviewed by Emily Henderson, B.Sc.Nov 20 2020 Today, the U.S. Food and Drug Administration approved Zokinvy (lonafarnib) capsules to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in patients one year of age and older. Zokinvy is not approved for use in patients with
0 Comments
Omalizumab (Xolair) maintained efficacy for chronic rhinosinusitis with nasal polyps, a researcher reported. In an open-label extension study of two, 24-week clinical trials, omalizumab was associated with significant improvements in nasal polyp scores (mean change -0.97, 95% CI -1.25 to -0.69), nasal congestion scores (mean change -0.99, 95% CI -1.14 to -0.83), and Sino-Nasal Outcome
0 Comments
Psoriatic arthritis is a heterogeneous inflammatory disorder that affects both women and men, with musculoskeletal symptoms typically occurring at age 40 to 60. Approximately 2-4% of individuals in the general population have psoriasis, and 20-30% of these develop psoriatic arthritis, usually at a later time, but concurrently in some cases. In the prospective Toronto Psoriasis
0 Comments